摘要:
The present invention is related to new diselenobis benzoic acid amides of primary heterocyclic amines of the general formula I ##STR1## process for producing the same and process for treating certain diseases in human beings by administration of the same to the humans suffering from such diseases.
摘要:
The invention relates to new 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines of the Formula I ##STR1## and acid addition salts thereof and a process for the treatment of inflammatory and allergic processes in humans.
摘要:
The invention relates to new .omega.-aryl-alkylthienyl compounds having the Formula I ##STR1## i.e. omega-aryl-alkyl thienyl alkanoic acids and, respectively, omega-aryl-alkyl thienyl alkenoic acids, the alkali metal salts of such acids and certain esters thereof. The invention further relates to processes for the treatment of chronically inflammatory processes in humans.
摘要:
The invention relates to new benzisoselenazolones of the general formula I ##STR1## and to the use thereof in the treatment of inflammatory diseases in humans.
摘要:
The invention relates to new benzisoselenazolethiones of the general formula I ##STR1## and to processes for the treatment of various diseases by administering them to such beings.
摘要:
The present invention relates to new S-(carbamoylphenylselenyl) derivatives of glutathione and of .alpha.-aminomercaptocarboxylic acids of the general formula (I) ##STR1##
摘要:
The invention relates to the new use of certain benzisothiazoles corresponding to the following general formula: ##STR1## wherein R.sub.1 represents chlorine, fluorine or bromine, and R.sub.2 represents hydrogen, chlorine, fluorine or bromine, in the treatment of phlogistic and/or arteriosclerotic processes.
摘要:
The invention relates to new benzisoselenazolones of the general formula I ##STR1## and a process for the treatment of humans suffering from inflammatory diseases of the rheumatic type.
摘要:
Anti-inflammatory benzylselanobenzamides made from anilines and benzylamines have the formula I ##STR1## are disclosed wherein R is hydrogen, methyl or ethyl;R.sup.1 and R.sup.2 are the same or different and, taken separately, are hydrogen, fluorine, chlorine, bromine, C.sub.1 to C.sub.4 alkyl, C.sub.1 to C.sub.4 alkoxy, hydroxy, cyano, amino, dimethylamino or nitro; andR.sup.3 and R.sup.4 are the same or different and, taken separately, are hydrogen, fluorine, chlorine, bromine, C.sub.1 to C.sub.4 alkyl, C.sub.1 to C.sub.4 alkoxy, hydroxy, cyano, or nitro and, taken together, represent methylenedioxy; andn is 0.1 or 2.
摘要翻译:由苯胺和苄胺制成的抗炎苄苯磺酰苯甲酰胺具有式I(I),其中R是氢,甲基或乙基; R 1和R 2相同或不同,分别为氢,氟,氯,溴,C 1至C 4烷基,C 1至C 4烷氧基,羟基,氰基,氨基,二甲基氨基或硝基; R 3和R 4相同或不同,分别为氢,氟,氯,溴,C 1至C 4烷基,C 1至C 4烷氧基,羟基,氰基或硝基,并且一起表示亚甲二氧基; n为0.1或2。
摘要:
Pharmaceutical preparation containing phospholipids for the therapeutic treatment of rheumatic diseases which contain in addition to the antiphlogistically acting oxicam derivatives of the general formula ##STR1## special 1,2-diacyl-glycero-3-phosphocholines wherein 75-86% by weight of the acyl radicals are unsaturated fatty acid radicals, and the preparation thereof.